These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 16361623)
1. Low rectal cancer: a call for a change of approach in abdominoperineal resection. Nagtegaal ID; van de Velde CJ; Marijnen CA; van Krieken JH; Quirke P; ; J Clin Oncol; 2005 Dec; 23(36):9257-64. PubMed ID: 16361623 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295 [TBL] [Abstract][Full Text] [Related]
3. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Weiser MR; Quah HM; Shia J; Guillem JG; Paty PB; Temple LK; Goodman KA; Minsky BD; Wong WD Ann Surg; 2009 Feb; 249(2):236-42. PubMed ID: 19212176 [TBL] [Abstract][Full Text] [Related]
5. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy. Liang JT; Lai HS; Lee PH Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719 [TBL] [Abstract][Full Text] [Related]
6. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534 [TBL] [Abstract][Full Text] [Related]
7. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes after total mesorectal excision for rectal cancer. Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534 [TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
11. Abdominoperineal resection or anterior resection for rectal cancer: patient preferences before and after treatment. Zolciak A; Bujko K; Kepka L; Oledzki J; Rutkowski A; Nowacki MP Colorectal Dis; 2006 Sep; 8(7):575-80. PubMed ID: 16919109 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Salerno GV; Daniels IR; Moran BJ; Heald RJ; Thomas K; Brown G Dis Colon Rectum; 2009 Apr; 52(4):632-9. PubMed ID: 19404067 [TBL] [Abstract][Full Text] [Related]
13. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [TBL] [Abstract][Full Text] [Related]
14. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Baik SH; Kim NK; Lee KY; Sohn SK; Cho CH; Kim MJ; Kim H; Shinn RK Ann Surg Oncol; 2008 Mar; 15(3):721-8. PubMed ID: 18058183 [TBL] [Abstract][Full Text] [Related]
16. A proposed approach for the selection of the proper surgical therapy to obtain an adequate margin of resection in locally advanced ultra-low rectal cancer after modern preoperative CRX management. Echenique I; Cabanillas F; Texidor V; Cáceres J; Isenberg G; Claudio C; Ayala R; Madera F Bol Asoc Med P R; 2009; 101(2):53-5. PubMed ID: 19954103 [TBL] [Abstract][Full Text] [Related]
17. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. García-Granero E; Faiz O; Muñoz E; Flor B; Navarro S; Faus C; García-Botello SA; Lledó S; Cervantes A Cancer; 2009 Aug; 115(15):3400-11. PubMed ID: 19479978 [TBL] [Abstract][Full Text] [Related]
18. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626 [TBL] [Abstract][Full Text] [Related]
19. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. West NP; Finan PJ; Anderin C; Lindholm J; Holm T; Quirke P J Clin Oncol; 2008 Jul; 26(21):3517-22. PubMed ID: 18541901 [TBL] [Abstract][Full Text] [Related]